Health Condition 1: D239- Other benign neoplasm of skin, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Anurag Mittal
Eligibility
Inclusion criteria
Inclusion criteria: All willing participants of all genders and of all age groups with a clinical suspicion of Benign Skin Growth shall be included in the study after obtaining consent.
Exclusion criteria
Exclusion criteria: 1. Patients with clinical suspicion of malignant skin lesions. 2. Dermoscopic features s/o malignancy. 3. Use of any topical or systemic medication for 15 days prior to visit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A well-documented dermoscopic atlas of benign skin growths can aid dermatologists in making faster, more accurate diagnoses, particularly in resource-limited settings where access to histopathology is restricted. Additionally, it can serve as a reference for training clinicians in dermoscopic interpretation, improving overall diagnostic competency.Timepoint: At the end of the study (After 2 years) | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactAnurag Mittal
Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research
Outcome results
None listed